ASLAN Pharmaceuticals Ltd. EBITDA 2018-2024 | ASLN
ASLAN Pharmaceuticals Ltd. ebitda from 2018 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| ASLAN Pharmaceuticals Ltd. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-43 |
| 2022 | $-48 |
| 2021 | $-34 |
| 2020 | $-16 |
| 2019 | $-45 |
| 2018 | $-42 |
| 2017 | $-39 |
| 2016 | $-9 |
| ASLAN Pharmaceuticals Ltd. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-9 |
| 2023-12-31 | $-13 |
| 2023-09-30 | $-10 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-18 |
| 2022-12-31 | $-13 |
| 2022-09-30 | $-10 |
| 2022-06-30 | $-12 |
| 2022-03-31 | $-12 |
| 2021-06-30 | $-15 |
| 2021-03-31 | $-7 |
| 2020-12-31 | $-6 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-29 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-7 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $-11 |
| 2018-09-30 | $-11 |
| 2018-06-30 | $-11 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-14 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $-9 |
| 2017-03-31 | $-8 |
